Skip to main content

BNP PARIBAS ARBITRAGE, SA

Position in NKTR — Nektar Therapeutics

CIK 1166588 NEW YORK, NY

Position in NKTR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,340,352
-$7,404,379 QoQ
Shares Held
19,200
-84.2% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#111
of 239 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NKTR Over Time

Shares Held

Position Value (USD)

Derivatives in NKTR

reported options exposure · as of Jun 30, 2021
CallValue
$9,094
CallShares
35
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,275,701,265 across 414 Biotechnology names. NKTR ranks #112 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NKTR

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,340,352 19,200
2026-03-31 $8,744,731 121,539
2025-12-31 $8,891,399 210,298
2025-09-30 $24,694 434
2025-06-30 $5,788 224
2025-03-31 $198,619 292,087
2024-12-31 $290,804 312,693
2024-09-30 $310,499 238,846
2024-06-30 $14,979 12,080
2024-03-31 $2,483 2,670
2023-12-31 $136,281 243,359
2023-09-30 $147,574 245,958
2023-06-30 $94,284 162,559
2023-03-31 $101,776 145,395
2022-12-31 $132,449 58,606
2022-09-30 $323,001 100,938
2022-06-30 $1,194,704 314,396
2022-03-31 $1,298,159 240,846
2021-12-31 $1,725,875 127,748
2021-09-30 $1,320,131 73,504
2021-06-30 $1,179,218 68,719
2021-06-30 $9,094 530
2021-03-31 $1,417,680 70,884
2020-12-31 $1,147,534 67,502
2020-09-30 $860,208 51,851
2020-06-30 $1,247,212 53,852
2020-03-31 $4,467,373 250,273